PPAR agonist 4

• Description :

  PPAR agonist 4 (Compound 12) is an orally active agonist for peroxisome proliferator-activated receptor (PPAR), which activates PPARα, PPARδ and PPARγ with EC50s of 0.7, 0.7 and 1.8 μM, respectively. PPAR agonist 4 exhibits anti-liver fibrosis efficacy[1].

• UNSPSC :

  12352005

• Target :

  PPAR

• Type :

  Reference compound

• Related Pathways :

  Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor

• Applications :

  Metabolism-protein/nucleotide metabolism

• Field of Research :

  Others

• Assay Protocol :

  https://www.medchemexpress.com/ppar-agonist-4.html

• Solubility :

  10 mM in DMSO

• Smiles :

  CC1=CC(CN2CCN(CC2)C3=NC=C(C=C3)C(F)(F)F)=CC(C)=C1OC(C)(C(O)=O)C

• Molecular Formula :

  C23H28F3N3O3

• Molecular Weight :

  451.48

• References & Citations :

  [1]Sun G, et al., Design, synthesis, and biological evaluation of piperazine derivatives as pan-PPARs agonists for the treatment of liver fibrosis. Eur J Med Chem. 2024 Apr 5;269:116344.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  PPARα; PPARγ; PPARδ